[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20001871L - Nye 3,6-hemiacetaler fra klassen 9a-azalider - Google Patents

Nye 3,6-hemiacetaler fra klassen 9a-azalider

Info

Publication number
NO20001871L
NO20001871L NO20001871A NO20001871A NO20001871L NO 20001871 L NO20001871 L NO 20001871L NO 20001871 A NO20001871 A NO 20001871A NO 20001871 A NO20001871 A NO 20001871A NO 20001871 L NO20001871 L NO 20001871L
Authority
NO
Norway
Prior art keywords
group
individually
represents hydrogen
carbon atoms
individually represents
Prior art date
Application number
NO20001871A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001871D0 (no
Inventor
Gabrijela Kobrehel
Gorjana Lazarevski
Mladen Vinkovic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HR970551A external-priority patent/HRP970551B1/xx
Priority claimed from HR980497A external-priority patent/HRP980497B1/xx
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of NO20001871D0 publication Critical patent/NO20001871D0/no
Publication of NO20001871L publication Critical patent/NO20001871L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20001871A 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider NO20001871L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR970551A HRP970551B1 (en) 1997-10-16 1997-10-16 Novel o-methyl azythromycin derivatives
HR980497A HRP980497B1 (en) 1998-09-10 1998-09-10 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PCT/HR1998/000005 WO1999020639A2 (en) 1997-10-16 1998-10-13 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES

Publications (2)

Publication Number Publication Date
NO20001871D0 NO20001871D0 (no) 2000-04-11
NO20001871L true NO20001871L (no) 2000-04-17

Family

ID=26317108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001871A NO20001871L (no) 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider

Country Status (26)

Country Link
US (1) US6369035B1 (xx)
EP (2) EP1036083B9 (xx)
JP (1) JP2001520234A (xx)
KR (1) KR100554549B1 (xx)
CN (1) CN1281615C (xx)
AR (1) AR018014A1 (xx)
AT (2) ATE267835T1 (xx)
AU (1) AU755315B2 (xx)
BG (1) BG64650B1 (xx)
BR (1) BR9812808A (xx)
CA (1) CA2306963C (xx)
DE (2) DE69824201T2 (xx)
DK (2) DK1437359T3 (xx)
EE (1) EE04681B1 (xx)
ES (2) ES2222610T3 (xx)
HK (1) HK1032785A1 (xx)
HU (1) HUP0004085A3 (xx)
IL (2) IL135648A0 (xx)
NO (1) NO20001871L (xx)
NZ (1) NZ503897A (xx)
PL (1) PL191087B1 (xx)
PT (2) PT1036083E (xx)
RU (1) RU2220148C2 (xx)
SI (2) SI1437359T1 (xx)
SK (1) SK285914B6 (xx)
WO (1) WO1999020639A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200200435T2 (tr) * 1998-11-03 2002-07-22 Pfizer Products Inc. Yeni makrolit antibiyotikler.
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
CA2476448A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Antibiotic conjugates
WO2003070174A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US20060099660A1 (en) 2002-02-15 2006-05-11 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
AU2003264910A1 (en) * 2003-05-30 2005-01-21 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) * 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
WO2008106225A1 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US9145436B2 (en) 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
EP2831083A4 (en) * 2012-03-27 2016-03-09 Michael W Burnet INFLAMMATORY MAKROLIDE
JP7184520B2 (ja) * 2018-01-22 2022-12-06 旭化成株式会社 トランス型脂環式カーボネートの製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
WO1999000124A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment

Also Published As

Publication number Publication date
KR100554549B1 (ko) 2006-03-03
EP1036083B9 (en) 2005-01-12
DK1437359T3 (da) 2007-04-30
US6369035B1 (en) 2002-04-09
DK1036083T5 (da) 2005-04-04
EP1437359A2 (en) 2004-07-14
EE04681B1 (et) 2006-08-15
ATE267835T1 (de) 2004-06-15
HUP0004085A3 (en) 2003-05-28
KR20010031160A (ko) 2001-04-16
BG104445A (en) 2001-02-28
DE69836697D1 (de) 2007-02-01
ES2279242T3 (es) 2007-08-16
BR9812808A (pt) 2005-04-12
SI1036083T1 (en) 2004-10-31
ES2222610T3 (es) 2005-02-01
DK1036083T3 (da) 2004-09-27
DE69824201D1 (de) 2004-07-01
SI1437359T1 (sl) 2007-06-30
HUP0004085A2 (hu) 2001-04-28
JP2001520234A (ja) 2001-10-30
PL191087B1 (pl) 2006-03-31
IL135648A0 (en) 2001-05-20
EP1036083A2 (en) 2000-09-20
EP1036083B1 (en) 2004-05-26
AU755315B2 (en) 2002-12-12
CA2306963C (en) 2007-05-01
WO1999020639A2 (en) 1999-04-29
NO20001871D0 (no) 2000-04-11
EP1437359A3 (en) 2005-03-30
HK1032785A1 (en) 2001-08-03
AR018014A1 (es) 2001-10-31
DE69836697T2 (de) 2007-10-04
BG64650B1 (bg) 2005-10-31
SK5522000A3 (en) 2000-11-07
IL135648A (en) 2007-03-08
SK285914B6 (sk) 2007-11-02
RU2220148C2 (ru) 2003-12-27
PL340372A1 (en) 2001-01-29
DE69824201T2 (de) 2005-09-22
EE200000226A (et) 2001-06-15
AU9362298A (en) 1999-05-10
CA2306963A1 (en) 1999-04-29
CN1281615C (zh) 2006-10-25
WO1999020639A3 (en) 1999-07-08
PT1036083E (pt) 2004-10-29
CN1280585A (zh) 2001-01-17
NZ503897A (en) 2002-10-25
EP1437359B1 (en) 2006-12-20
PT1437359E (pt) 2007-04-30
ATE348836T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
NO20001871L (no) Nye 3,6-hemiacetaler fra klassen 9a-azalider
UA39869C2 (uk) Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція
RS49850B (sr) Derivati 1,4-benzotiazepin-1,1-dioksida supstituisani radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
PL358428A1 (en) 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
IE41528L (en) Furfuryl-benzomorphane derivatives.
KR840003646A (ko) 20-아미노틸로신 유도체의 제조방법
IE43847L (en) N-substituted phenylpiperidine derivatives.
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
ES2142771A1 (es) Nuevos derivados de la 6-(4-penilbutoxi) hexilamina y procedimiento para la obtencion de salmeterol.
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их
KR870003107A (ko) 키산틴 유도체의 제조방법
EA199900156A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
RS49832B (sr) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja
DE3788149D1 (de) Prostazyklin-(PGI2)-Analoge.
CO4810380A1 (es) Derivados de eritromicina
NO943861L (no) Trisyklisk forbindelse til bruk som tachykinin-antagonist
DE69935250D1 (de) Oleandomycin-derivate
IL66384A (en) Indolin-2-one(3,4-dihydroquinol-2-one or quinol-2-one)-oxyalkylsulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
ES8506011A1 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol
ES459705A1 (es) Procedimiento para la preparacion de derivados de hidracina-piridacina.
EA200200574A1 (ru) НОВЫЕ ЦИКЛИЧЕСКИЕ α-АМИНО-γ-ГИДРОКСИАМИДНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application